Financial Ratios Universal Health Services, Inc.
Equities
UHS
US9139031002
Healthcare Facilities & Services
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
168.94 USD | -1.10% |
|
-7.44% | -5.84% |
Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 6.76 | 6.56 | 4.99 | 5.35 | 7.41 | |||||
Return on Total Capital | 8.29 | 8.16 | 6.03 | 6.44 | 9.04 | |||||
Return On Equity % | 15.89 | 15.67 | 10.8 | 11.82 | 17.94 | |||||
Return on Common Equity | 15.92 | 15.95 | 11.24 | 11.89 | 17.82 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 40.3 | 39.95 | 38.53 | 39.5 | 42.47 | |||||
SG&A Margin | 1 | 0.94 | 0.98 | 0.99 | 0.93 | |||||
EBITDA Margin % | 16.18 | 15.25 | 12.26 | 12.21 | 14.34 | |||||
EBITA Margin % | 11.76 | 11.03 | 7.92 | 8.23 | 10.65 | |||||
EBIT Margin % | 11.76 | 11.03 | 7.92 | 8.23 | 10.65 | |||||
Income From Continuing Operations Margin % | 8.24 | 7.81 | 4.9 | 5.04 | 7.35 | |||||
Net Income Margin % | 8.17 | 7.84 | 5.04 | 5.03 | 7.22 | |||||
Net Avail. For Common Margin % | 8.14 | 7.83 | 5.04 | 5.02 | 7.22 | |||||
Normalized Net Income Margin | 6.72 | 6.58 | 4.45 | 4.1 | 5.79 | |||||
Levered Free Cash Flow Margin | 9.44 | 2.22 | 0.93 | 2.17 | 6.06 | |||||
Unlevered Free Cash Flow Margin | 10.03 | 2.64 | 1.52 | 3.08 | 6.8 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.92 | 0.95 | 1.01 | 1.04 | 1.11 | |||||
Fixed Assets Turnover | 2.09 | 2.12 | 2.12 | 2.21 | 2.34 | |||||
Receivables Turnover (Average Receivables) | 7.03 | 7.27 | 7.12 | 6.71 | 7.17 | |||||
Inventory Turnover (Average Inventory) | 39.4 | 38.22 | 38.73 | 39.68 | 41.59 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.32 | 1.14 | 1.33 | 1.4 | 1.27 | |||||
Quick Ratio | 1.19 | 0.94 | 1.11 | 1.17 | 1.04 | |||||
Operating Cash Flow to Current Liabilities | 0.95 | 0.45 | 0.52 | 0.63 | 0.94 | |||||
Days Sales Outstanding (Average Receivables) | 52.08 | 50.17 | 51.27 | 54.38 | 51.06 | |||||
Days Outstanding Inventory (Average Inventory) | 9.29 | 9.55 | 9.42 | 9.2 | 8.8 | |||||
Average Days Payable Outstanding | 26.86 | 29.49 | 28.66 | 26.42 | 25.03 | |||||
Cash Conversion Cycle (Average Days) | 34.51 | 30.23 | 32.03 | 37.16 | 34.83 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 65.47 | 73.56 | 88.3 | 86.53 | 73.27 | |||||
Total Debt / Total Capital | 39.57 | 42.38 | 46.89 | 46.39 | 42.29 | |||||
LT Debt/Equity | 59.35 | 71.74 | 85.8 | 83.33 | 71.58 | |||||
Long-Term Debt / Total Capital | 35.87 | 41.33 | 45.56 | 44.68 | 41.31 | |||||
Total Liabilities / Total Assets | 52.46 | 52.66 | 55.76 | 55.6 | 53.26 | |||||
EBIT / Interest Expense | 12.46 | 16.35 | 8.34 | 5.67 | 8.98 | |||||
EBITDA / Interest Expense | 18.2 | 24 | 13.94 | 9.09 | 12.88 | |||||
(EBITDA - Capex) / Interest Expense | 11.5 | 13.96 | 8.18 | 5.51 | 7.85 | |||||
Total Debt / EBITDA | 2.11 | 2.23 | 2.97 | 2.85 | 2.05 | |||||
Net Debt / EBITDA | 1.5 | 2.17 | 2.91 | 2.78 | 2 | |||||
Total Debt / (EBITDA - Capex) | 3.34 | 3.83 | 5.07 | 4.7 | 3.37 | |||||
Net Debt / (EBITDA - Capex) | 2.37 | 3.73 | 4.97 | 4.6 | 3.28 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 1.59 | 9.37 | 5.99 | 6.59 | 10.82 | |||||
Gross Profit, 1 Yr. Growth % | 2.64 | 8.45 | 2.21 | 9.28 | 19.14 | |||||
EBITDA, 1 Yr. Growth % | 3.65 | 3.08 | -14.76 | 6.11 | 30.19 | |||||
EBITA, 1 Yr. Growth % | 3.49 | 2.57 | -23.9 | 10.77 | 43.36 | |||||
EBIT, 1 Yr. Growth % | 3.49 | 2.57 | -23.9 | 10.77 | 43.36 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 15.13 | 3.66 | -33.48 | 9.49 | 61.7 | |||||
Net Income, 1 Yr. Growth % | 15.84 | 5.05 | -31.87 | 6.24 | 59.11 | |||||
Normalized Net Income, 1 Yr. Growth % | 8.68 | 7.42 | -28.35 | -1.64 | 56.45 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 20.37 | 7.55 | -22.67 | 11.93 | 64.42 | |||||
Accounts Receivable, 1 Yr. Growth % | 10.77 | 1.02 | 15.52 | 10.93 | -2.7 | |||||
Inventory, 1 Yr. Growth % | 19.09 | 8.62 | 5.65 | -0.7 | 1.82 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 6.86 | 9.32 | 2.1 | 2.91 | 6.59 | |||||
Total Assets, 1 Yr. Growth % | 15.5 | -2.84 | 3.06 | 3.51 | 3.6 | |||||
Tangible Book Value, 1 Yr. Growth % | 51.66 | -13 | -5.52 | 10.69 | 24.19 | |||||
Common Equity, 1 Yr. Growth % | 14.77 | -3.6 | -2.78 | 3.86 | 8.41 | |||||
Cash From Operations, 1 Yr. Growth % | 64.08 | -62.56 | 12.71 | 27.29 | 63.05 | |||||
Capital Expenditures, 1 Yr. Growth % | 15.33 | 17 | -14.22 | 1.23 | 27.02 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 72.78 | -74.31 | -55.56 | 149.01 | 208.93 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 58.04 | -71.22 | -38.82 | 115.44 | 144.6 | |||||
Dividend Per Share, 1 Yr. Growth % | -66.67 | 300 | 0 | 0 | 0 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 3.59 | 5.41 | 7.67 | 6.29 | 8.68 | |||||
Gross Profit, 2 Yr. CAGR % | 3.49 | 5.5 | 5.28 | 5.68 | 14.1 | |||||
EBITDA, 2 Yr. CAGR % | 5.45 | 3.37 | -6.27 | -4.9 | 17.54 | |||||
EBITA, 2 Yr. CAGR % | 5.19 | 3.03 | -11.66 | -8.19 | 26.01 | |||||
EBIT, 2 Yr. CAGR % | 5.19 | 3.03 | -11.66 | -8.19 | 26.01 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 9.28 | 9.25 | -16.96 | -14.66 | 33.06 | |||||
Net Income, 2 Yr. CAGR % | 10.03 | 10.31 | -15.4 | -14.92 | 30.02 | |||||
Normalized Net Income, 2 Yr. CAGR % | 8.35 | 7.87 | -12.28 | -16.05 | 24.05 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 15 | 13.78 | -8.8 | -6.97 | 35.66 | |||||
Accounts Receivable, 2 Yr. CAGR % | 7.15 | 5.78 | 8.03 | 13.2 | 3.89 | |||||
Inventory, 2 Yr. CAGR % | 13.35 | 13.74 | 7.12 | 2.42 | 0.55 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 8.52 | 8.08 | 5.65 | 2.51 | 4.74 | |||||
Total Assets, 2 Yr. CAGR % | 9.38 | 5.93 | 0.06 | 3.28 | 3.55 | |||||
Tangible Book Value, 2 Yr. CAGR % | 24.19 | 14.87 | -9.34 | 2.26 | 17.24 | |||||
Common Equity, 2 Yr. CAGR % | 8.27 | 5.18 | -3.19 | 0.49 | 6.11 | |||||
Cash From Operations, 2 Yr. CAGR % | 36.07 | -21.62 | -35.04 | 19.78 | 44.06 | |||||
Capital Expenditures, 2 Yr. CAGR % | 4.87 | 16.16 | 0.18 | -6.81 | 13.4 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 53.59 | -33.39 | -66.24 | 5.04 | 177.1 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 43.83 | -32.56 | -58.04 | 14.83 | 129.55 | |||||
Dividend Per Share, 2 Yr. CAGR % | -29.29 | 15.47 | 100 | 0 | 0 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 3.55 | 5.48 | 5.6 | 7.31 | 7.78 | |||||
Gross Profit, 3 Yr. CAGR % | 2.51 | 5.11 | 4.39 | 6.6 | 9.99 | |||||
EBITDA, 3 Yr. CAGR % | 2.66 | 4.65 | -3.07 | -2.31 | 5.6 | |||||
EBITA, 3 Yr. CAGR % | 2.02 | 4.31 | -6.87 | -4.74 | 6.51 | |||||
EBIT, 3 Yr. CAGR % | 2.02 | 4.31 | -6.87 | -4.74 | 6.51 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 7.3 | 7.37 | -7.4 | -8.94 | 5.6 | |||||
Net Income, 3 Yr. CAGR % | 7.86 | 8.34 | -6.06 | -8.73 | 4.82 | |||||
Normalized Net Income, 3 Yr. CAGR % | 4.01 | 7.92 | -5.88 | -8.87 | 3.31 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 12.06 | 12.46 | 0.04 | -2.36 | 12.48 | |||||
Accounts Receivable, 3 Yr. CAGR % | 4.92 | 5.07 | 8.93 | 8.99 | 7.63 | |||||
Inventory, 3 Yr. CAGR % | 11.82 | 11.75 | 10.97 | 4.45 | 2.22 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 7.69 | 8.79 | 6.05 | 4.73 | 3.85 | |||||
Total Assets, 3 Yr. CAGR % | 7.79 | 5.14 | 4.97 | 1.2 | 3.39 | |||||
Tangible Book Value, 3 Yr. CAGR % | 35.55 | 10.29 | 7.62 | -3.1 | 9.1 | |||||
Common Equity, 3 Yr. CAGR % | 8.18 | 4.16 | 2.46 | -0.9 | 3.06 | |||||
Cash From Operations, 3 Yr. CAGR % | 23.68 | -11.5 | -11.53 | -18.71 | 32.75 | |||||
Capital Expenditures, 3 Yr. CAGR % | 9.47 | 8.77 | 5 | 0.53 | 3.32 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 19.05 | -15.37 | -41.8 | -34.27 | 50.49 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 16.28 | -15.87 | -34.71 | -27.61 | 47.75 | |||||
Dividend Per Share, 3 Yr. CAGR % | -20.63 | 25.99 | 10.06 | 58.74 | 0 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 5.03 | 5.3 | 5.18 | 5.8 | 6.82 | |||||
Gross Profit, 5 Yr. CAGR % | 3.84 | 4.01 | 3.61 | 5.34 | 8.17 | |||||
EBITDA, 5 Yr. CAGR % | 2.43 | 2.57 | -1 | 0.72 | 4.7 | |||||
EBITA, 5 Yr. CAGR % | 1.54 | 1.7 | -3.68 | -0.88 | 5.11 | |||||
EBIT, 5 Yr. CAGR % | 1.54 | 1.7 | -3.68 | -0.88 | 5.11 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 4.88 | 5.74 | -3.16 | -2.05 | 7.04 | |||||
Net Income, 5 Yr. CAGR % | 6.76 | 7.14 | -2.13 | -1.64 | 6.99 | |||||
Normalized Net Income, 5 Yr. CAGR % | 3.76 | 4.17 | -2.9 | -2.39 | 5.11 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 10.21 | 10.61 | 3.2 | 4.24 | 13 | |||||
Accounts Receivable, 5 Yr. CAGR % | 5.83 | 3.94 | 6.15 | 8.25 | 6.89 | |||||
Inventory, 5 Yr. CAGR % | 10.41 | 10.53 | 9.92 | 7.92 | 6.68 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 8.28 | 7.58 | 6.87 | 6.23 | 5.52 | |||||
Total Assets, 5 Yr. CAGR % | 6.99 | 4.88 | 4.63 | 4.39 | 4.4 | |||||
Tangible Book Value, 5 Yr. CAGR % | 40.18 | 31.46 | 15.4 | 7.01 | 11.37 | |||||
Common Equity, 5 Yr. CAGR % | 8.25 | 6.08 | 3.48 | 2.67 | 3.91 | |||||
Cash From Operations, 5 Yr. CAGR % | 17.18 | -7.9 | -4.4 | -0.11 | 7.52 | |||||
Capital Expenditures, 5 Yr. CAGR % | 14.03 | 10.48 | 5.65 | 2.25 | 8.28 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 12.02 | -19.62 | -28.06 | -7.67 | 8.7 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 10.94 | -18.25 | -22.65 | -4.72 | 7.97 | |||||
Dividend Per Share, 5 Yr. CAGR % | -12.94 | 14.87 | 14.87 | 14.87 | 5.92 |
- Stock Market
- Equities
- UHS Stock
- Financials Universal Health Services, Inc.
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition